Immune Checkpoint Inhibitor-Induced Primary Hyperparathyroidism in a Small-Cell Lung Cancer Patient: A Case Report.

Zhang, Ying; Cui, Yangang; Li, Yan; Cong, Lei

Zhang, Ying; Cui, Yangang; Li, Yan; Cong, Lei.

Afiliación

Zhang Y; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
Cui Y; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
Li Y; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
Cong L; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.

Medicina (Kaunas) ; 59(2)2023 Jan 22.

Article en En | MEDLINE | ID: mdl-36837417

Asunto(s)

Hiperparatiroidismo Primario; Neoplasias Pulmonares; Carcinoma Pulmonar de Células Pequeñas; Masculino; Humanos; Persona de Mediana Edad; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Neoplasias Pulmonares/tratamiento farmacológico

Palabras clave

hypercalcemia; hyperparathyroidism; hypophosphatemia; immune checkpoint inhibitors; immune-related adverse events

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 3_diarrhea / 4_diarrhoeal_infections / 6_endocrine_disorders / 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Hiperparatiroidismo Primario / Carcinoma Pulmonar de Células Pequeñas / Neoplasias Pulmonares Límite: Humans / Male / Middle aged Idioma: En Revista: Medicina (Kaunas) Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google